Herbalife acquires Bioniq for $150M
Herbalife, the health and wellness company, has agreed to acquire assets from Bioniq, the UK-based personalised supplements company focused on making health more accessible and actionable, for $150 million. The transaction aims to advance Herbalife’s mission of becoming a technology-enabled, data-driven health and wellness platform.
“The future of health and wellness is becoming more personalised and informed by data,” said Herbalife Chief Executive Officer, Stephan Gratziani. “By combining Bioniq’s personalised supplement technology with Pro2col and the power of our global distributor network, we are expanding our ability to deliver personalised wellness at global scale.”
Bioniq develops personalised supplement formulas using its patented product personalisation engine, an individual’s health background, and a proprietary database of biomarkers. Bioniq’s personalised supplement formulations are designed for a broad range of individuals, from everyday wellness consumers to elite athletes, including Cristiano Ronaldo, who has previously invested in the company.
Bioniq will complement Herbalife’s prior acquisitions of Pro2col and Link BioSciences by enabling Herbalife to offer a broader range of personalised nutritional supplements across multiple delivery formats. Combining Bioniq’s offering with Herbalife’s global manufacturing expertise will enable the Company to expand personalised nutrition at scale and speed.
Vadim Fedotov, Founder of Bioniq, commented: “I founded Bioniq in 2019 with a vision to help people optimise their wellbeing through a science-driven approach to nutrition that incorporates biomarker and lifestyle data. I am excited to join Herbalife with its global distributor network and commitment to advancing wellness at scale.”
Vadim Fedotov will join Herbalife’s leadership team following the completion of the transaction. Key members of the Bioniq team will also transition to Herbalife.
As a long-time global nutrition partner of Herbalife and Bioniq shareholder, Cristiano Ronaldo shares Herbalife’s vision to accelerate the availability of personalised nutritional supplements at scale through its global distributor network.
“Throughout my career, biometrics and personalised nutrition have been central to helping me perform and compete at the highest level. As a longtime Herbalife and Bioniq user, I’ve experienced firsthand how a tailored approach to nutrition can help optimise performance,” said Cristiano Ronaldo. “I’m delighted to see Bioniq’s personalised supplements become part of Herbalife’s expanding access to nutritional supplements, helping people take a more informed approach to their health, wellness and performance.”
The transaction will close in Q2 2026, subject to regulatory approvals and customary closing conditions. The $55 million purchase price will be paid over five years, including an initial payment of $10 million at closing. The transaction value also includes up to $95 million of contingent payments based on future performance.
As part of the transaction, Herbalife also obtained a call option to acquire Bioniq LAB, a separate platform focused on small molecules and peptides. The call option provides Herbalife with strategic flexibility to evaluate potential longer-term opportunities in this area in a disciplined and capital-efficient manner.
Bioniq’s personalised nutritional supplements are expected to be offered later this year through Herbalife independent distributors for customers in select countries in Europe and the United States, with additional markets to follow.
For more startup news, check out the other articles on the website, and subscribe to the magazine for free. Listen to The Cereal Entrepreneur podcast for more interviews with entrepreneurs and big-hitters in the startup ecosystem.
